Pages that link to "Q48967375"

The following pages link to Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. (Q48967375):

Displaying 21 items.

• Inhibition of Striatal Soluble Guanylyl Cyclase-cGMP Signaling Reverses Basal Ganglia Dysfunction and Akinesia in Experimental Parkinsonism (Q21090973) (← links)
• Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models (Q26852381) (← links)
• Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity (Q28185479) (← links)
• Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition (Q28394979) (← links)
• Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice (Q28586429) (← links)
• Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning (Q28588029) (← links)
• Temporal sequence learning, prediction, and control: a review of different models and their relation to biological mechanisms (Q36048788) (← links)
• Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy (Q40706904) (← links)
• Elevated intracranial dopamine impairs the glutamate‑nitric oxide‑cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy. (Q41864234) (← links)
• Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity (Q42028032) (← links)
• Electrical stimulation of the hippocampal fimbria facilitates neuronal nitric oxide synthase activity in the medial shell of the rat nucleus accumbens: Modulation by dopamine D1 and D2 receptor activation (Q42426464) (← links)
• Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model (Q42507934) (← links)
• Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease? (Q42785592) (← links)
• Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. (Q43163005) (← links)
• Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens (Q46078047) (← links)
• Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery. (Q46329271) (← links)
• Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism (Q46597028) (← links)
• Dopamine D2 receptor-dependent modulation of striatal NO synthase activity (Q48317923) (← links)
• Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: Evidence for a dopaminergic regulation of striatal nitric oxide release (Q48502195) (← links)
• Frequency-Dependent Corticostriatal Disinhibition Resulting from Chronic Dopamine Depletion: Role of Local Striatal cGMP and GABA-AR Signaling (Q52147479) (← links)
• Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity (Q63256021) (← links)